High-throughput prescreening of pharmaceuticals using a genome-wide bacterial bioreporter array

We assessed the applicability of multi-strain bacterial bioreporter bioassays to drug screening. To this end, we investigated the reactions of a panel of 15 luminescent recombinant Escherichia coli bacterial bioreporters to a library of 420 pharmaceuticals. The panel included bacterial bioreporters...

Ausführliche Beschreibung